Physician profile
Julie A Lyons
NPI 1750326583
$1,446.57
in general payments reported to CMS, 2019-2025
12 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $329 · 2023: $403 · 2024: $353 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $279.56 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $225.77 | 2021-2022 | |
| Abbott Laboratories | $153.43 | 2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $117.83 | 2022 | |
| Amgen INC. | $117.29 | 2024 | Krystexxa |
| Grifols USA, LLC | $115.75 | 2025 | Prolastin-C Liquid |
| Alnylam Pharmaceuticals INC. | $107.87 | 2025 | Amvuttra |
| Jazz Pharmaceuticals INC. | $100.04 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.07 | 2023 | |
| Sanofi-Aventis U.S. LLC | $81.88 | 2024 | |
| Novo Nordisk INC | $40.00 | 2023 | |
| Outset Medical INC | $24.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.